Interested in exploring biomarkers but unsure how to analyze RNA-sequencing data? In this webinar, our experts showcase how biologists can leverage the g.nome® platform's Guided Workflows to perform differential expression analyses from FASTQ files. This session is designed to help biologists uncover significant insights and drive their research forward.
Key Takeaways
- Simplifying RNASeq Analysis: Learn how to generate visualizations from publicly fetched data with minimal effort.
- Quality Assessment: Discover how to perform rigorous QC via simple visual reports.
- Identifying Biomarkers: See how to highlight strong candidates through differential expression analysis and gene set enrichment.
This webinar demonstrates how biologists can quickly and easily identify biomarkers using g.nome’s intuitive platform, even without extensive bioinformatics expertise. Watch the recording below to explore how these tools can enhance your research.
Moderator
Director of Business Development
Almaden Genomics
Hannah Schuyler graduated from The University of Texas and spent the beginning of her career focused on using digital analytics to inform a marketing strategy for pharmaceutical, biotech, and medical device clients. She has spent the last few years working with clients to help them identify data analysis solutions for NGS and genomic data.
Speaker
Chief Scientific Officer and Co-Founder
Almaden Genomics
Mark Kunitomi is the chief scientific officer and co-founder of Almaden Genomics. With over a decade of experience in research and development, he brings a wealth of knowledge and expertise to the company. Kunitomi received his doctorate from University of California, San Francisco. He focuses on the development of cutting-edge software and algorithms for the analysis and interpretation of bioinformatic data. He is a recognized leader in the field, with numerous publications and patents to his name. At Almaden Genomics, Kunitomi leads a team of highly skilled scientists and engineers, working to bring innovative solutions to the market and advancing the field of genomics.